Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) Return on Capital Employed [ROCE] (2025 - 2026)

Updated

Translational Development Acquisition (TDACU) recorded Return on Capital Employed [ROCE] of -0.78% in Q2 2026, down 0.35 percentage points from -0.43% a year earlier and down 0.30 percentage points from the prior quarter.

Analysis

Translational Development Acquisition (TDACU) Return on Capital Employed [ROCE] (2025 - 2026) Analysis & Trends

For FY2025, Translational Development Acquisition reported Return on Capital Employed [ROCE] of -0.53%, down 0.31 percentage points from FY2024.

  • Across earlier years, Return on Capital Employed [ROCE] came in at -0.22% in FY2024.
  • Per Business Quant, the preceding three quarters came in at -0.48% (Q1 2026), -0.52% (Q4 2025) and -0.51% (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.78%
Mar 31, 2026 -0.48%
Dec 31, 2025 -0.52%
Sep 30, 2025 -0.51%
Jun 30, 2025 -0.43%
Mar 31, 2025 -0.31%
API Access

Translational Development Acquisition Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TDACU&period=max&api_key=YOUR_API_KEY